1. Home
  2. BGLC vs LTRY Comparison

BGLC vs LTRY Comparison

Compare BGLC & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • LTRY
  • Stock Information
  • Founded
  • BGLC N/A
  • LTRY 2015
  • Country
  • BGLC Malaysia
  • LTRY United States
  • Employees
  • BGLC 30
  • LTRY N/A
  • Industry
  • BGLC Medical Specialities
  • LTRY Computer Software: Prepackaged Software
  • Sector
  • BGLC Health Care
  • LTRY Technology
  • Exchange
  • BGLC Nasdaq
  • LTRY Nasdaq
  • Market Cap
  • BGLC 9.1M
  • LTRY 8.8M
  • IPO Year
  • BGLC N/A
  • LTRY N/A
  • Fundamental
  • Price
  • BGLC $0.51
  • LTRY $1.29
  • Analyst Decision
  • BGLC
  • LTRY
  • Analyst Count
  • BGLC 0
  • LTRY 0
  • Target Price
  • BGLC N/A
  • LTRY N/A
  • AVG Volume (30 Days)
  • BGLC N/A
  • LTRY 325.1K
  • Earning Date
  • BGLC N/A
  • LTRY 08-20-2024
  • Dividend Yield
  • BGLC N/A
  • LTRY N/A
  • EPS Growth
  • BGLC N/A
  • LTRY N/A
  • EPS
  • BGLC N/A
  • LTRY N/A
  • Revenue
  • BGLC N/A
  • LTRY $6,626,564.00
  • Revenue This Year
  • BGLC N/A
  • LTRY N/A
  • Revenue Next Year
  • BGLC N/A
  • LTRY N/A
  • P/E Ratio
  • BGLC N/A
  • LTRY N/A
  • Revenue Growth
  • BGLC N/A
  • LTRY 75.84
  • 52 Week Low
  • BGLC N/A
  • LTRY $0.82
  • 52 Week High
  • BGLC N/A
  • LTRY $13.00
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 52.80
  • LTRY 47.82
  • Support Level
  • BGLC $0.46
  • LTRY $1.45
  • Resistance Level
  • BGLC $0.59
  • LTRY $2.20
  • Average True Range (ATR)
  • BGLC 0.05
  • LTRY 0.33
  • MACD
  • BGLC 0.00
  • LTRY 0.07
  • Stochastic Oscillator
  • BGLC 27.68
  • LTRY 33.91

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About LTRY Lottery.com Inc.

Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

Share on Social Networks: